ArticleFrontiers in public health2025
Influence of illness perception on depression and anxiety in individuals with schizophrenia during the COVID-19 pandemic.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cognitive behavioral therapy combined with aripiprazole in the treatment of schizophrenia: effects on cognitive function and psychological state.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the factors influencing depression and anxiety in individuals with schizophrenia during the COVID-19 pandemic, with the goal of providing evidence to support strategies for improving emotional disturbances during the pandemic. Methods: A cross-sectional study was conducted among 159 outpatients with schizophrenia between January and June 2023. Data were collected using a self-developed sociodemographic questionnaire, the Chinese version of the Illness Perception Questionnaire-Revised (IPQ-R), the Patient Health Questionnaire-9 (PHQ-9), and the 7-item Generalized Anxiety Disorder scale (GAD-7). Regression analysis was performed using SPSS version 27.0 to identify the factors associated with depression and anxiety. Results: Timeline cyclical and treatment control were significant predictors of depression among individuals with schizophrenia (R Conclusion: Illness perception concerning COVID-19 significantly influenced the severity of depression and anxiety in individuals with schizophrenia. Addressing these perceptions serves as an essential component of interventions aimed at improving mental health outcomes during the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.